Top compounds associated with response to PLXNB1


Feature Type Standardized
Nominal ANOVA
mRNA austocystin d CTRPv2 pan-cancer AAC 0.24 4e-09
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 8e-08
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.22 1e-07
mRNA pac-1 CTRPv2 pan-cancer AAC 0.21 3e-07
mRNA lapatinib CCLE pan-cancer AAC 0.25 6e-07
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 6e-07
mRNA neratinib CTRPv2 pan-cancer AAC 0.19 4e-06
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC 0.17 5e-06
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.22 6e-06
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 8e-06
Download CSV